This compound is a boronic ester derivative featuring a dioxaspirodecane ring system, commonly used as a pharmaceutical intermediate in the synthesis of boronate-containing molecules. Its structure contains multiple ether groups and heterocyclic rings, contributing to its utility in organic synthesis for pharmaceutical manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1106871-37-7
2-(Piperidino)pyridine-5-boronic acid pinacol ester
pharmaceutical intermediate
1-(2-Tetrahydropyranyl)-1H-pyrazole-5-boronic acid pinacol ester
pharmaceutical intermediate
2-Chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-amine
pharmaceutical intermediate
6FDA
pharmaceutical intermediate
2-(chloromethyl)-5-(trifluoromethyl)-1,3-benzothiazole
pharmaceutical intermediate
Methanesulfonic acid;4,4,5,5,5-pentafluoropentyl carbamimidothioate
pharmaceutical intermediate
N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide
pharmaceutical intermediate
2-(1,4-dioxaspiro[4.5]decan-8-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
JAEUAPKITKWJML-UHFFFAOYSA-N
B1(OC(C(O1)(C)C)(C)C)C2CCC3(CC2)OCCO3
—